The expression of TGM2 is increased in several types of cancers, including breast, ovarian, prostate, and pancreatic cancers5, and the enzymatic activity of TGM2 is augmented in various cancer-associated stress conditions, such as hypoxia, oxidative stress, endoplasmic reticulum stress, and chemotherapeutic treatment6–9. Here, TGM2 is linked to cancer.